Portfolio health stable — churn concentration in enterprise segment
Weekly customer health summary for leadership
Executive summary. Portfolio health score held at 78 despite two enterprise accounts entering critical status. NRR improved to 108% driven by Acme Corp and Northwind Labs expansion motions. At-risk ARR rose $340K primarily from StellarTech and Redwood Analytics — both flagged 14+ days before renewal conversations.
Priority actions
- StellarTech: Assign exec sponsor · schedule recovery plan · 47 days to renewal · $284K at risk
- Expansion pipeline: 41 accounts expansion-ready · $892K estimated uplift · prioritize Acme and NovaPay
- Support load: Ticket volume up 12% in mid-market cohort · correlate with health dips in Cascade and Helix